Vanadro Drug Development Consulting - Drake University - Fellow in Drug Development

Vanadro and Drake University have entered a collaboration to create the Post-Doctoral Drug Development Fellowship.

The fellowship, unique to the Midwest, will provide pharmacy graduates the opportunity to gain a solid foundation and competitive edge within the industry through intensive training in various aspects of new drug development.

The drug development fellow will work with many different industry partners to provide groundbreaking patient care to patients globally. The fellowship will provide interactions with drug companies, the Food and Drug Administration, research laboratories, and didactic training in numerous aspects of research. Additionally, the fellow will be able to gain teaching experience In Drake’s Doctor of Pharmacy program.

Some activities of the fellowship will include:

• Participation in various client meetings to provide insight and guidance into development of an appropriate clinical pharmacology plan.
• Development of study documents including protocols and protocol concepts, IND submission documents, and various synopses
• Engagement in literature reviews, data analysis, and reporting of data to client’s and various other stakeholder’s
• Management of pharmacokinetic responsibilities of contract research organizations (CROs)
• Evaluation of study design to ensure appropriateness and compliance within the recommendations of ICH/FDA guidelines
• Participation in hands on laboratory research training under the supervision of a Drake Professor
• Presentation of drug development topics to Drake University faculty and students in a lecture format

Applications must be submitted and completed online at https://drake.HireTouch.com. Applications will be closed on January 20, 2021.

Applications must include:

• Letter of interest
• Curriculum vitae
• Two letters of recommendation, and a list of references

As part of the interview, applicants will be asked to present a 40-minute seminar on drug development with a focus on Phase I or Phase II confirmatory studies.

Questions may be addressed to the current drug development fellow, Dr. Ivy Xue (Ivy.Xue@drake.edu).